FEMME-TAB 20/100 levonorgestrel 100mcg ethinylestradiol 20mcg film-coated tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

femme-tab 20/100 levonorgestrel 100mcg ethinylestradiol 20mcg film-coated tablet blister pack

aft pharmaceuticals pty ltd - levonorgestrel, quantity: 100 microgram; ethinylestradiol, quantity: 20 microgram - tablet, film coated - excipient ingredients: gelatin; macrogol 4000; magnesium stearate; maize starch; lactose monohydrate; titanium dioxide; hypromellose - oral contraception

LEVONORGESTREL-1 APOTEX levonorgestrel 1.5 mg tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

levonorgestrel-1 apotex levonorgestrel 1.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - levonorgestrel, quantity: 1.5 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; lactose monohydrate; poloxamer; magnesium stearate - emergency contraception within 72 hours of unprotected intercourse.

MICRONELLE 20 ED levonorgestrel 100 microgram and ethinylestradiol 20 microgram film-coated tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

micronelle 20 ed levonorgestrel 100 microgram and ethinylestradiol 20 microgram film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - levonorgestrel, quantity: 100 microgram; ethinylestradiol, quantity: 20 microgram - tablet, film coated - excipient ingredients: povidone; lactose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - oral contraception.

EVELYN 150/30 ED levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablet blister pack Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

evelyn 150/30 ed levonorgestrel 150 microgram and ethinylestradiol 30 microgram tablet blister pack

lupin australia pty limited - levonorgestrel, quantity: 150 microgram; ethinylestradiol, quantity: 30 microgram - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - oral contraception

MYZILRA- levonorgestrel and ethinyl estradiol kit Marekani - Kiingereza - NLM (National Library of Medicine)

myzilra- levonorgestrel and ethinyl estradiol kit

central texas community health centers - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.05 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use myzilra® tablets as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition. ny, ny: ardent media, inc., 1998. oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. known or suspected carcinoma of the breast. carcinoma of

MYZILRA- levonorgestrel and ethinyl estradiol Marekani - Kiingereza - NLM (National Library of Medicine)

myzilra- levonorgestrel and ethinyl estradiol

par pharmaceutical - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.05 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use myzilra® tablets as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition. ny, ny: ardent media, inc., 1998. oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. known or suspected carcinoma of the breast. carcinoma of

LEVORA- levonorgestrel and ethinyl estradiol kit Marekani - Kiingereza - NLM (National Library of Medicine)

levora- levonorgestrel and ethinyl estradiol kit

rebel distributors corp - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.15 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception.1 the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who have the following conditions:

LEVORA- levonorgestrel and ethinyl estradiol kit Marekani - Kiingereza - NLM (National Library of Medicine)

levora- levonorgestrel and ethinyl estradiol kit

physicians total care, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.15 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception.1 the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who have the following conditions: - thrombophlebitis or thromboembolic disorders thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast known or suspected carcinoma of the breast - c